Canadian Association of Radiopharmaceutical Scientists

January 15, 2016


ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and distribution business operations of Lantheus Medical Imaging (“LMI”), including pharmacies located in Dorval, Quebec; Quebec City, Quebec; Mississauga, Ontario; and Vancouver, British Columbia. Over the coming months, ISOLOGIC will integrate radiopharmaceutical and Gludef manufacturing and distribution under a single brand, while maintaining the highest level of product quality and customer service. (more)

August 18, 2015

On August 18, 2015, the FDA issued a MedWatch alert alerting healthcare professionals not to administer compounded or repackaged drugs to patients that have been stored in Becton-Dickinson (BD) 3 mL and 5 mL Syringes, unless there is no suitable alternative available.

March 16, 2015

Expanded medical isotope production part of Chalk River legacy - Tom Spears, Ottawa Citizen. When the Chalk River nuclear reactor is permanently shuttered, Canada will be in a much better position to provide medical isotopes than it was back in 2009. more

March 14, 2015

Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approach. Rogier Langea, Rob ter Heinea, Clemens Decristoforoe, Iván Peñuelasf, Philip H. Elsingab, Monique M.L. van der Westerlakena and N. Harry Hendriksec,d. read more

March 12-13, 2015

Health Canada's 2015 Regulatory Workshop on Radiopharmaceuticals
Please note the content of all the talks will be available in the Members section once the authors  permission is given.

March 09, 2015

Call for abstracts - The Isotope Production Symposium (one of many sessions of interest) that will be held at the Pacific Basin Conference (Pacifichem) in Honolulu, Hawaii in December, 2015 ( ).  
Please consider submitting an abstract (due April 3rd), and/or let your potentially interested colleagues, collaborators, students and post docs know about this symposium and encourage them to consider submitting an abstract. Click here for the flier.
Information concerning submission may be found at
Please note that this request to submit does not guarantee that your contributed abstract will be accepted for inclusion in the symposium.  Acceptance will depend upon the quality, significance and relevance of the work described in the abstract.

February 06, 2015

Government of Canada Announces Extension of National Research Universal (NRU) Reactor
OTTAWA, Feb. 6, 2015 /CNW/ - The Honourable Greg Rickford, Canada's Minister of Natural Resources, today announced the Government of Canada's decision to support the extension of the operations of the National Research Universal (NRU) reactor from October 31, 2016, until March 31, 2018. The NRU is operated by Canadian Nuclear Laboratories Ltd. (CNL), a subsidiary of Atomic Energy of Canada Limited.
Today's announcement of the extension of the NRU is designed to help support global medical isotope demand between 2016 and 2018 in the unexpected circumstances of shortages, and Canadian Nuclear Laboratories will now begin decommissioning the NRU after March 31, 2018. read more

Last updated January 19, 2016
Home | About Us | Radiopharmacy News | Members Only | | Meetings | Radiopharmacy Job Postings | Contact Us |
Terms of Use
Copyright © 2016 Canadian Association of Radiopharmaceutical Scientists | Webmaster Mariusz Bereznicki